U.S. Infusion Pump Market

U.S. Infusion Pump Market Size (2023 to 2028)

The size of the infusion pump market in the United States is forecasted to grow at a healthy CAGR during the forecast period. The U.S. infusion pump market accounted for a significant share of the global market in 2023.

The infusion pump device supplies the required nutrients, fluids, and medicines (chemotherapy drugs, antibiotics, insulin, etc.) to the patient's body. Moreover, Ambulatory Infusion Pump will not restrict a patient's mobility; therefore, for aging and disabled people with chronic diseases, who are provided medical care at home, Ambulatory Infusion Pump will work. According to the data released by NCBI, above 80% of the senior population in the United States has been diagnosed with a chronic disease. Data, according to Ankota, says that 70% of people who avail of home healthcare services are over 65. Since older patients under medical treatment at home are more, the requirement for infusion pumps is higher, driving the growth rate of the infusion pump market.

Unlike traditional open surgery, minimally invasive surgery is performed by making small incisions. This surgery is usually not painful and helps the patients recover faster, minimizing the period of hospitalization. Therefore, an infusion pump must provide medications and nutrients during surgical procedures. Almost 15 million minimally invasive surgeries are performed annually in the United States. Since the infusion pump caters to the medication needs of the patient's body, it is in heavy demand. Therefore, the demand for the infusion pump will boost the growth rate of its market.

Besides the advantages of the infusion pump, there are also medication errors affiliated with the infusion pump. Entry, rate, unit, and decimal errors are a few problems with having an infusion pump. Entry errors and decimal errors can lead to an overdose of the medication than the required amount. Moreover, rate errors can lead to the delivery of the medication at a faster pace. According to a Patient Safety in Pennsylvania study, infusion pump errors have been identified in 1,004 events across 132 hospitals. Therefore, the medication errors associated with infusion pumps can hinder the growth of the infusion pump market.

This market research report on the U.S. infusion pump market has been segmented and sub-segmented into the following categories.

 By Type:

• Accessories and Consumables
• Devices

By Product:

• Volumetric infusion pumps
• Insulin infusion pumps
• Enteral infusion pumps
• Ambulatory infusion pumps
• Syringe infusion pumps
• Patient-controlled analgesia (PCA) pumps
• Implantable infusion pumps

By Application:

• Chemotherapy/Oncology
• Diabetes
• Gastroenterology
• Analgesia/pain management
• Pediatrics/neonatology
• Hematology
• Other applications

By End-User:

• Hospitals
• Home care settings
• Ambulatory care settings
• Academic and research institutes

By Country:

• The United States

An infusion pump is placed beside the patient's bed to administer medications, fluids, insulin, nutrients, or chemotherapeutic drugs to the patient's body. The user can set the delivery rate and quantity of the medication or fluid before administering the fluid; therefore, this is employed during various surgical procedures. According to data collected by Statista, surgical procedures are highly performed in the United States in California, Florida, and Texas. Thus, the infusion pump market in these states will boost the market's growth rate.

The Census Bureau claims that the aging population of the United States is 56 million, and the data from the Centers for Disease Control and Prevention states that by 2030 the aging population in the United States will double. As a result, older patients will require healthcare for chronic diseases. The aging population increases the risk of chronic diseases; therefore, medical institutions struggle to provide equal healthcare. Moreover, older patients with chronic diseases prefer to undergo treatment at home. Thus, the demand for home health care increases the need for infusion pumps, increasing the revenue of its market.

According to data collected by The Census Bureau, the senior population of the United States is 56 million, and PRB finds that one-fourth of this senior population lives in California, Florida, and Texas. Thus, these states accommodate older people. Therefore, home healthcare services might be more prevalent in these states. In addition, the hike in home health care services increases the need for infusion pumps. Therefore, the infusion pump market is more likely to develop in these states.

KEY MARKET PLAYERS:

Terumo Corporation, Avanos Medical, Inc., Nipro Corporation, Insulet Corporation, Tandem Diabetes Care, Inc., Jms Co., Ltd., Roche Diagnostics, Zyno Medical, Teleflex, Inc., Mindray Medical International Limited, Micrel Medical Devices S.A., Ypsomed Holding Ag, Becton, Dickinson And Company, B. Braun Melsungen AG, Baxter International Inc., Fresenius Kabi, ICU Medical, Inc., Smiths Medical, Medtronic PLC and Moog Inc. are a few of the prominent companies operating in the U.S. infusion pump market.